LEADER 02035oam  2200505   450 
001 9910706804903321
005 20180420122442.0
035   $a(CKB)5470000002459423
035   $a(OCoLC)797511239$z(OCoLC)652257651$z(OCoLC)654493806$z(OCoLC)798532288$z(OCoLC)1011984958$z(OCoLC)1022045096
035   $a(EXLCZ)995470000002459423
100   $a20120629d1998      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aReview of the internal administration's study critical of Clinton drug policy and White House supression of study $ehearing before the Subcommittee on National Security, International Affairs, and Criminal Justice of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, October 1, 1996
210  1$aWashington :$cU.S. Government Printing Office,$d1998.
215   $a1 online resource (iii, 146 pages) $cillustrations, maps
320   $aIncludes bibliographical references.
517   $aReview of the internal administration's study critical of Clinton drug policy and White House supression of study 
606   $aDrug control$zUnited States
606   $aDrug abuse$xGovernment policy$zUnited States
606   $aDrug abuse$xGovernment policy$2fast
606   $aDrug control$2fast
607   $aUnited States$2fast
608   $aLegislative hearings.$2lcgft
615  0$aDrug control
615  0$aDrug abuse$xGovernment policy
615  7$aDrug abuse$xGovernment policy.
615  7$aDrug control.
801  0$bOCLCE
801  1$bOCLCE
801  2$bOCLCQ
801  2$bOCLCF
801  2$bOCLCQ
801  2$bOCLCO
801  2$bOCLCQ
801  2$bNJR
801  2$bOCLCQ
801  2$bGPO
906   $aBOOK
912   $a9910706804903321
996   $aReview of the internal administration's study critical of Clinton drug policy and White House supression of study$93464282
997   $aUNINA